APA (7th ed.) Citation

Regierer, A. C., Hasseli-Fräbel, R., Schäfer, M., Hoyer, B. F., Krause, A., Lorenz, H., . . . Müller-Ladner, U. (2021). TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD. RMD Open, 7(3), . https://doi.org/10.1136/rmdopen-2021-001896

Chicago Style (17th ed.) Citation

Regierer, Anne C., et al. "TNFi Is Associated with Positive Outcome, but JAKi and Rituximab Are Associated with Negative Outcome of SARS-CoV-2 Infection in Patients with RMD." RMD Open 7, no. 3 (2021). https://doi.org/10.1136/rmdopen-2021-001896.

MLA (9th ed.) Citation

Regierer, Anne C., et al. "TNFi Is Associated with Positive Outcome, but JAKi and Rituximab Are Associated with Negative Outcome of SARS-CoV-2 Infection in Patients with RMD." RMD Open, vol. 7, no. 3, 2021, https://doi.org/10.1136/rmdopen-2021-001896.